Overview
NARP syndrome (Neuropathy, Ataxia, and Retinitis Pigmentosa) is a rare mitochondrial disorder caused by pathogenic variants in the MT-ATP6 gene, which encodes a subunit of mitochondrial ATP synthase (complex V). The condition is characterized by a triad of sensory or sensorimotor neuropathy, cerebellar ataxia, and retinitis pigmentosa (progressive degeneration of the retina). NARP syndrome is part of a clinical spectrum that also includes maternally inherited Leigh syndrome (MILS), with the severity largely determined by the heteroplasmy level of the mitochondrial DNA mutation, most commonly the m.8993T>G or m.8993T>C variant. When the mutation load is typically between 70% and 90%, the NARP phenotype predominates, whereas higher mutation loads (above 90%) are more commonly associated with the more severe Leigh syndrome. The disease primarily affects the nervous system and the eyes. Additional clinical features may include learning difficulties, developmental delay, seizures, dementia, proximal muscle weakness, and hearing loss. Cardiac conduction defects and short stature have also been reported in some patients. Symptoms typically emerge in childhood or young adulthood, though the age of onset and severity can vary considerably even within the same family due to differences in mitochondrial mutation load across tissues. There is currently no cure for NARP syndrome. Treatment is supportive and symptomatic, focusing on management of neurological symptoms, seizure control with appropriate anticonvulsants, physical and occupational therapy for ataxia and neuropathy, and ophthalmological monitoring for retinitis pigmentosa. Nutritional supplementation with coenzyme Q10, B vitamins, and other mitochondrial cofactors has been tried, though evidence for efficacy remains limited. Genetic counseling is important for affected families, particularly regarding the complexities of mitochondrial inheritance and the unpredictable nature of heteroplasmy transmission from mother to offspring.
Also known as:
Clinical phenotype terms— hover any for plain English:
Mitochondrial
Passed from mother to child through the energy-producing parts of the cell
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for NARP syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for NARP syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to NARP syndrome.
Community
No community posts yet. Be the first to share your experience with NARP syndrome.
Start the conversation →Latest news about NARP syndrome
No recent news articles for NARP syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about NARP syndrome
What is NARP syndrome?
NARP syndrome (Neuropathy, Ataxia, and Retinitis Pigmentosa) is a rare mitochondrial disorder caused by pathogenic variants in the MT-ATP6 gene, which encodes a subunit of mitochondrial ATP synthase (complex V). The condition is characterized by a triad of sensory or sensorimotor neuropathy, cerebellar ataxia, and retinitis pigmentosa (progressive degeneration of the retina). NARP syndrome is part of a clinical spectrum that also includes maternally inherited Leigh syndrome (MILS), with the severity largely determined by the heteroplasmy level of the mitochondrial DNA mutation, most commonly t
How is NARP syndrome inherited?
NARP syndrome follows a mitochondrial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat NARP syndrome?
3 specialists and care centers treating NARP syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.